Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi’s Jevtana doubles progression-free survival in metastatic castration-resistant prostate cancer

October 1, 2019
Manufacturing and Production, Research and Development ESMO 2019, Jevtana, Sanofi, pharma, prostate cancer

Sanofi was present at the 2019 European Society of Medical Oncology (ESMO) Congress in Barcelona this year to reveal new …

News

Chris Whitty begins role as England’s Chief Medical Officer

October 1, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

London consultant and public health professor, Chris Whitty, has begun his role as England’s Chief Medical Officer, taking over from …

Appointment
roche__tree

Roche’s Tecentriq plus chemo shows promise in first-line, advanced bladder cancer

October 1, 2019
Manufacturing and Production, Research and Development Cancer, ESMO 2019, Roche, breast cancer, pharma, tecentriq

Roche has revealed data from an interim analysis of its immunotherapy Tecentriq (atezolizumab) at the 2019 European Society for Medical …

News
lynparza

AZ and MSD’s parp inhibitor Lynparza cuts risk of progression and death in prostate cancer

October 1, 2019
Manufacturing and Production

AstraZeneca and MSD have shown in their Phase 3 PROfound trial, PARP inhibitor Lynparza (olaparib) reduced the risk of disease …

News
Sobi Logo

Sobi to acquire Dova for $915m to broaden hematology franchise

October 1, 2019
Manufacturing and Production

Sobi is to buy Dova Pharmaceuticals for $915 million in a bid to grow Sobi’s hematology portfolio, with liver cancer …

News
10257-itokwqzqhdt9

ESMO studies show CD4K/6 inhibitor and fulvestrant improves OS in breast cancer

October 1, 2019
Manufacturing and Production

Detailed findings from two Phase III trials presented at the European Society for Medical Oncology showed that treatment with a …

News
albert_bourla2019_300x170_1

Pfizer CEO Albert Bourla to Succeed Ian Read as Executive Chairman

September 30, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pfizer’s executive chairman Ian Read, is to be succeeded by CEO Albert Bourla with a date to start the post …

Appointment
shutterstock

The world needs a better plan for cancer survival by 2030

September 30, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Roche, UN General Assembly, United Nations, feature, opinion, pharma

Beginning on 24 September, the UN will convene in New York for its annual General Assermbly. Dr Christian Rommel, Roche´s …

Feature
astrazeneca_building_white

AZ’s Tagrisso extends median overall survival by over 3 years in metastatic, EGFR-mutated lung cancer

September 30, 2019
Research and Development, Sales and Marketing AstraZeneca, Cancer, ESMO 2019, Tagrisso, lung cancer, pharma

AstraZeneca took to the stage at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona to present new …

News
merck-keytruda

MSD’s Keytruda meets primary endpoint in triple-negative breast cancer

September 30, 2019
Sales and Marketing

MSD have announced results from its Phase 3, KEYNOTE-522 trial that pathological complete response (pCR) in patients with early triple-negative …

News

Roche secures US paediatric approval for Rituxan in two rare forms of vasculitis

September 30, 2019
Sales and Marketing MabThera, Rituxan, Roche, pharma, vasculitis

Roche has revealed that Rituxan (rituximab), also known as MabThera, has been awarded US approval from the FDA in combination …

News

Novartis reports positive Phase 3 PALLADIUM results in uncontrolled asthma

September 30, 2019
Sales and Marketing

Novartis has announced that its investigational, once-daily, fixed-dose inhaled QMF149 (indacaterol acetate and mometasone furoate) was superior to mometasone furoate …

News
lynparza

AZ and Merck’s ovarian cancer combo improves progression-free survival

September 30, 2019
Sales and Marketing

AstraZeneca and Merck have announced that their combination treatment for newly diagnosed ovarian cancer significantly improved progression free survival. The …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 27, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

Another week comes to a close, and it’s time to review the biggest stories of the week. Check out the …

News
takeda_deerfield_hq

Takeda’s Entyvio outperforms AbbVie’s Humira in moderate-to-severe ulcerative colitis

September 27, 2019
Medical Communications, Research and Development AbbVie, Entyvio, Humira, Takeda, pharma, ulcerative colitis

Takeda has released strong new data for Entyvio (vedolizumab), showing that the gut-selective biologic outperformed AbbVie’s blockbuster anti-tumour necrosis factor-alpha …

News
abbvie_0

AbbVie’s Mavyret scores FDA label expansion to shorten treatment duration for hepatitis C patients

September 27, 2019
Medical Communications, Sales and Marketing AbbVie, FDA, hepatitis, hepatitis C, mavyret, pharma

The FDA has chosen to expand the existing label for AbbVie’s Mavyret (glecaprevir/pibrentasvir), it has been revealed, to include the …

News
darzalex-product-shot---100mg-vial-2-hr

FDA approves Genmab’s Darzalex combo in newly diagnosed multiple myeloma

September 27, 2019
Medical Communications, Sales and Marketing FDA, Genmab, darzalex, pharma

Genmab’s CD38 inhibitor Darzalex (daratumumab) has been awarded marketing authorisation from the FDA in combination with bortezomib, thalidomide and dexamethasone …

News
Catapult Stevenage site

Cell and Gene Therapy Catapult doubles capacity at UK site

September 26, 2019
Manufacturing and Production, Medical Communications

The United Kingdom’s Cell and Gene Therapy Catapult (CGT Catapult) has added six additional modules of cleanroom space at its …

News
research

Male infertility linked to prostate cancer risk

September 26, 2019
Research and Development

Research published in the British Medical Journal has found a link that men who have fertility treatment have a higher …

News

Iran reveals plans to domestically produce 135 strategic drugs

September 26, 2019
Manufacturing and Production Iran, pharma, production

Iran has announced plans to promote self-sufficiency within the country with regard to its medicines production, with an aim of …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026